Developing effective cancer vaccines: design and monitoring are critical.
Armstrong
A
A
Dermime
S
S
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology / Q000627:therapeutic use*; D019496:Cancer Vaccines; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000276:immunology / Q000628:therapy; D023381:Endpoint Determination; D005818:Genetic Engineering; D006801:Humans; D012107:Research Design; D016896:Treatment Outcome
D000888:Antibodies, Anti-Idiotypic; D019496:Cancer Vaccines